Worldline's Q3 2024 sales were €1,163 million, showing a 1.1% organic decline. UBS has reiterated its Sell recommendation and lowered the target price for the company to €5, down from €5.25, indicating a potential downside of 18%. Despite the revenue challenges, Worldline is sticking to its fiscal 2024 guidance, which includes a target of approximately 1% organic sales growth, adjusted EBITDA of around €1.1 billion, and free cash flow of about €0.2 billion. UBS mentioned that although the company has confirmed its 2024 targets, it still faces significant revenue hurdles.

Worldline's Q3 2024 sales declined by 1.1% organically, amounting to €1,163 million. UBS has reiterated its Sell recommendation for the company and has lowered the target price to €5, indicating a potential downside of 18%. Despite these challenges, Worldline remains committed to its fiscal 2024 guidance. This guidance includes a target of approximately 1% organic sales growth, adjusted EBITDA of around €1.1 billion, and free cash flow of about €0.2 billion. However, UBS has highlighted that the company still faces significant revenue hurdles.

Worldline's Q3 2024 sales showed a 1.1% organic decline, reaching €1,163 million. UBS has reiterated its Sell recommendation for the company and has revised the target price to €5, down from €5.25, indicating a potential downside of 18%. Despite these challenges, Worldline remains confident in its fiscal 2024 guidance. The company aims for approximately 1% organic sales growth, adjusted EBITDA of around €1.1 billion, and free cash flow of about €0.2 billion. However, UBS has cautioned that the company still needs to overcome significant revenue hurdles.